OVs	Oncolytic viruses
IFNs	Interferons
TLR	Toll-like receptors
Ad	Adenovirus
MYXV	Myxoma virus
VSV	Vesicular Stomatitis Virus
MYC	Myelocytomatosis
eIF2B	Eukaryotic translation initiation factor 2B subunit alpha
Rae1	ribonucleic acid export 1
Nup98	Nucleoporin 98
eIF4E	Eukaryotic translation initiation factor 4E
KEAP1	Kelch-like ECH-associated protein 1
ROS	Reactive oxygen species
NRF2	nuclear factor erythroid 2-related factor 2
PGAM5	Phosphoglycerate mutase 5
ER	Endoplasmic reticulum
DAMPs	Damage associate molecular pattern
APCs	Antigen presenting cells
DCs	Dendritic cells
TNF-α	Tumour necrosis factor-α
IL-1	Interleukin 1
NK	Natural killer
RIPK3	Receptor Interacting Protein Kinase 3
ZBP1	Z-DNA binding protein 1
cIAP2	cellular inhibitor of apoptosis protein 2
CAR	Coxsackie adenovirus receptor
CRAds	Conditionally Replicative Adenoviruses
T-VEC	Talimogene laherparepvec
ECHO	7 ECHO virus type 7
HSV-1	Herpes simplex virus 1
GM-CSF	Granulocyte-macrophage colony-stimulating factor
MM	multiple myeloma
MV	Measles virus
MVNIS	Measles virus encoding the human thyroidal sodium iodide symporter
MTD	Maximal tolerated dose
RRMM	Multiple myeloma relapsed or refractory
CR	Complete remission
MUC1	Mucin 1
TK	thymidine kinase
AdEHCD40L	CD40 ligand transgene
SCID	Severe combined immunodeficiency disease (SCID)
NF-κB	nuclear factor kappa-light-chain-enhancer of activated B cells
TAAs	Tumour-associated antigens
PBMC	peripheral blood mononuclear cell
MAGE	Melanoma-associated antigen
AML	Acute myeloid leukemia
GFP	Green fluorescent protein
BM	Bone marrow
MOI	Minimum multiplicity of infection
CMV	Cytomegalovirus
CVA21	Coxsackievirus A21
DAF	Decay Accelerating Factor
ICAM-1	Intercellular Adhesion Molecule 1
TRAIL	TNF-related apoptosis-inducing ligand (TRAIL)
A4	rAd5pz-zTRAIL-RFP-SΔ24E1a
ZA4	Zipper-like dimerization domain
RVs	Rhabdoviruses
NRRPs	Non-proliferating rhabdovirus-originated particles
PD-L1	Programmed death ligand 1
Ab	Antibody
Mcl-1	Myeloid cell leukemia 1 protein
Bcl-2	B-cell lymphoma 2
Bax	Bcl-2-associated X protein
Bak	Bcl-2 homologous antagonist killer
OVV	Oncolytic vaccinia virus
ALT	Alternative lengthening of telomeres
PML NBs	Promyelocytic leukemia nuclear bodies
CML	Chronic myeloid leukaemia
NDV	Newcastle disease virus
CLL	Chronic lymphocytic leukemia
ADCC	Antibody-dependent cellular cytotoxicity
MCL	Mantle cell lymphoma
CPA	Cyclophosphamide
CTCLs	Cutaneous T-cell lymphomas
EBV	Epstein-Barr Virus
ICP0	Infected cell protein 0
GvHD	Graft-versus-host disease
allo-HSCT	Allogeneic Hematopoietic Cell Transplantation
HDAC	Histone deacetylase HDAC
VPA	Valproic acid
NKG2D	Natural Killer-gene complex 2D
CTLA-4	Cytotoxic T lymphocyte antigen 4
CAR	Chimeric Antigen Receptor
EMA	European Medicines Agency
FDA	Food and Drug Administration